Iclusig bulk order
Ended Awarded Last action
- Contract number
- 36C26025F0052
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $339,293
Award facts
- Contract value 100% obligated
- $339,293.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $4,813 | |
| Funding Only Action | -$481 | |
| Original award | $334,961 |
About this award
This is a federal contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a subsidiary of the Japanese pharmaceutical company Takeda Pharmaceutical Company Limited. The contract is for the supply of ICLUSIG (ponatinib), a specialty oncology medication used to treat certain types of leukemia.
The contract is a Delivery Order placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. It has a ceiling value of $339,293.34 and is a Firm Fixed Price agreement, with no set-aside designation. The contract has an ultimate completion date of September 30, 2025.
Takeda Pharmaceuticals America, Inc. is the prime contractor for this award, and the funding agency is the VA. The contract is part of a larger Blanket Purchase Agreement (BPA) valued at over $123.5 million that Takeda holds with the VA's National Acquisition Center for the supply of ICLUSIG. This BPA allows for streamlined procurement of the oncology medication by various VA medical facilities nationwide, supporting the VA's mission to provide comprehensive healthcare services to veterans.
Quick answers
Who was awarded contract 36C26025F0052?
36C26025F0052 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 15, 2024.
How much is contract 36C26025F0052 worth?
The government has obligated $339,293 on 36C26025F0052.
Is contract 36C26025F0052 an order under another contract?
Yes. 36C26025F0052 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0052 competed?
The extent of competition for 36C26025F0052 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award